BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17359357)

  • 1. The astrocytic response towards invasive meningiomas.
    Zeltner L; Schittenhelm J; Mittelbronn M; Roser F; Tatagiba M; Mawrin C; Kim YJ; Bornemann A
    Neuropathol Appl Neurobiol; 2007 Apr; 33(2):163-8. PubMed ID: 17359357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of SPARC expression and basement membrane intactness at the tumour-brain border of invasive meningiomas.
    Schittenhelm J; Mittelbronn M; Roser F; Tatagiba M; Mawrin C; Bornemann A
    Neuropathol Appl Neurobiol; 2006 Oct; 32(5):525-31. PubMed ID: 16972886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microglial/macrophagic response at the tumour-brain border of invasive meningiomas.
    Grund S; Schittenhelm J; Roser F; Tatagiba M; Mawrin C; Kim YJ; Bornemann A
    Neuropathol Appl Neurobiol; 2009 Feb; 35(1):82-8. PubMed ID: 19187060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microscopic anatomy of the brain-meningioma interface.
    Nakasu S; Fukami T; Jito J; Matsuda M
    Brain Tumor Pathol; 2005; 22(2):53-7. PubMed ID: 18095106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The basement membrane at the tumour-brain interface of brain-invasive grade I meningiomas.
    Fritz J; Roser F; Tatagiba M; Bornemann A
    Neuropathol Appl Neurobiol; 2005 Jun; 31(3):339-42. PubMed ID: 15885070
    [No Abstract]   [Full Text] [Related]  

  • 7. SPARC: a potential diagnostic marker of invasive meningiomas.
    Rempel SA; Ge S; Gutiérrez JA
    Clin Cancer Res; 1999 Feb; 5(2):237-41. PubMed ID: 10037170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive meningioma is associated with a low expression of E-cadherin and beta-catenin.
    Utsuki S; Oka H; Sato Y; Kawano N; Tsuchiya B; Kobayashi I; Fujii K
    Clin Neuropathol; 2005; 24(1):8-12. PubMed ID: 15696778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 expression in human meningiomas: an immunohistochemical analysis.
    Lewy-Trenda I; Omulecka A; Janczukowicz J; Papierz W
    Pol J Pathol; 2004; 55(1):33-7. PubMed ID: 15195704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of extracellular matrix-degrading proteins in classic, atypical, and anaplastic meningiomas.
    von Randow AJ; Schindler S; Tews DS
    Pathol Res Pract; 2006; 202(5):365-72. PubMed ID: 16563650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The accuracy of meningioma grading: a 10-year retrospective audit.
    Willis J; Smith C; Ironside JW; Erridge S; Whittle IR; Everington D
    Neuropathol Appl Neurobiol; 2005 Apr; 31(2):141-9. PubMed ID: 15771707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of Correlation Between Immunohistochemical Expression of SPARC and Invasion in Different Grades of Meningiomas.
    Rooprai HK; Martin AJ; King A; Appadu UD; Gullan RW; Thomas NWM; Pilkington GJ
    Anticancer Res; 2020 Jun; 40(6):3081-3089. PubMed ID: 32487602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meningiomas: new prognostic factors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical meningiomas: WHO moved the goalposts?
    Smith SJ; Boddu S; Macarthur DC
    Br J Neurosurg; 2007 Dec; 21(6):588-92. PubMed ID: 18071986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical staining for claudin-1 can help distinguish meningiomas from histologic mimics.
    Hahn HP; Bundock EA; Hornick JL
    Am J Clin Pathol; 2006 Feb; 125(2):203-8. PubMed ID: 16393681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ectopia of meningeal fibroblasts and reactive gliosis in the cerebral cortex of the mouse model of muscle-eye-brain disease.
    Yang Y; Zhang P; Xiong Y; Li X; Qi Y; Hu H
    J Comp Neurol; 2007 Dec; 505(5):459-77. PubMed ID: 17924568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active lysyl oxidase (LOX) correlates with focal adhesion kinase (FAK)/paxillin activation and migration in invasive astrocytes.
    Laczko R; Szauter KM; Jansen MK; Hollosi P; Muranyi M; Molnar J; Fong KS; Hinek A; Csiszar K
    Neuropathol Appl Neurobiol; 2007 Dec; 33(6):631-43. PubMed ID: 17931358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of osteopontin and LMX1A expression with World Health Organization grade in meningiomas and gliomas.
    Tsai WC; Lee HS; Lin CK; Chen A; Nieh S; Ma HI
    Histopathology; 2012 Nov; 61(5):844-56. PubMed ID: 22882568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of p63 immunoreactivity with tumor grade in meningiomas.
    Rushing EJ; Olsen C; Man YG
    Int J Surg Pathol; 2008 Jan; 16(1):38-42. PubMed ID: 18203782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligodendrogliomas in relation to astrocytes differentiation. Clinicopathologic and immunohistochemical study.
    Tena-Suck ML; Moreno-Jiménez S; Alonso M; Aguirre-Crux L; Sánchez A
    Ann Diagn Pathol; 2008 Oct; 12(5):313-21. PubMed ID: 18774492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.